← board
TLRY
distress 3/10 · well-funded / low risk$4.10-1%today-80% from 52w high
Revenue
$634M
Liquidity
$228M
Runway
2.4 yrs
Shares 1y
-89%
Price & events
-55.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.4%
1D
-5.7%
1W
-11.1%
1M
-40.9%
3M
-54.7%
6M
-44.6%
1Y
-78.3%
2Y
-97.0%
5Y
-95.4%
All
Overview
- Market Cap
- $477.85M
- Volume
- 307.81K
- 52 Week Range
- $4.10 – $21.00
- Total Shares
- 116.55M
- Float Shares
- 444.06M
- Short %
- 14.52%
- % Held by Insiders
- 0.71%
- % Held by Institutions
- 9.38%
- RVOL
- 0.09x
- Beta
- 1.90
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 2
- 2026-07-28earningsEarningsEarnings releaseyahoo
- 2026-03-02partnershipTilray UK acquired certain business operations and assets of BrewDog Group for £33M, including brewery, brewpubs, and IP.SEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
buy · target $9 (+127% upside) · 8 analysts
- 2026-07-14TD CowenBuy
- 2026-04-02Roth CapitalNeutral → Buy
- 2026-03-30TD CowenBuy
- 2026-01-20Roth CapitalNeutral
- 2025-08-25JefferiesBuy
- 2025-07-29Zelman & AssocNeutral
Competitors
- none identified
Recent news
- 2026-07-23Tilray enters its pouch era with Zonna | 2026-07-23 | Investing News - Stockhouse
- 2026-07-23Tilray subsidiary launches spirits line in Texas By Investing.com - Investing.com Canada
- 2026-07-23Tilray Brands Launches ZONNA, Introducing New THC Pouches for Cannabis Consumers - GlobeNewswire
- 2026-07-23Tilray Brands Company Profile & Introduction - Moomoo
- 2026-07-22Tilray Brands Inc. stock falls Wednesday, underperforms market - MarketWatch
- 2026-07-21TLRY Q4'25 Earnings: revenue estimate is 249.64M USD - TradingView
- 2026-07-21Tilray Brands (TLRY) Expected to Release Earnings on Tuesday - MarketBeat
- 2026-07-20Tilray Beats Suit Over Hemp Product Protein Claim, For Now - Law360
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.